DRW Holdings »

BioMarin Pharmaceutical shares owned by DRW Holdings

Quarter-by-quarter ownership of BioMarin Pharmaceutical (BMRN) shares owned by DRW Holdings from 13F filings

Historical chart of DRW Holdings investment in BioMarin Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including BioMarin Pharmaceutical held by DRW Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioMarin Pharmaceutical by DRW Holdings

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.5M 17k 87.34

More positions owned by DRW Holdings

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Spdr Gold Tr Gold Shs Call Option (GLD)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Grayscale Ethereum Com Unt (ETHE)
NVIDIA Corporation Call Option (NVDA)
Microsoft Corporation Call Option (MSFT)
Oracle Corporation Call Option (ORCL)
Amazon Call Option (AMZN)
Apple Call Option (AAPL)
Tesla Motors Call Option (TSLA)
Ishares Tr Msci India Etf (INDA)
Facebook Inc cl a Call Option (META)
Alphabet Inc Class A cs Call Option (GOOGL)
Marvell Technology Put Option (MRVL)
Pdd Holdings Sponsored Ads Call Option (PDD)

View all positions for DRW Holdings

Top funds holding BioMarin Pharmaceutical

BlackRock
Vanguard Group
PRIMECAP Management Company
Dodge & Cox
State Street Corporation
Viking Global Investors
Capital Research Global Investors
Ameriprise Financial
UBS Group
venBio Select Advisor
Elliott Investment Management
Geode Capital Management
Jpmorgan Chase & Co
Bank of New York Mellon
Pictet Asset Management Holding SA

View all funds holding BioMarin Pharmaceutical